Steven Cohen Boston Scientific Corp Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Boston Scientific Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,381,819 shares of BSX stock, worth $305 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

3,381,819

Previous 3,125,022 8.22%

Holding current value

$305 Million

Previous $241 Million 17.76%

% of portfolio

0.78%

Previous 0.67%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $18.7 Million - $21.6 Million	256,797 Added 8.22%	3,381,819 $283 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $51.1 Million - $59 Million	758,833 Added 32.07%	3,125,022 $241 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $135 Million - $161 Million	-2,344,656 Reduced 49.77%	2,366,189 $162 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $83.2 Million - $98.9 Million	-1,710,909 Reduced 26.64%	4,710,845 $272 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $147 Million - $160 Million	2,931,055 Added 83.97%	6,421,754 $339 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $85 Million - $93.4 Million	1,708,999 Added 95.92%	3,490,699 $189 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $71.4 Million - $79.2 Million	1,583,831 Added 800.44%	1,781,700 $89.1 Million
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $108 Million - $129 Million	-2,727,904 Reduced 93.24%	197,869 $9.16 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $6.71 Million - $20 Million	182,829 Added 6.67%	2,925,773 $113 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $780,354 - $1.04 Million	22,144 Added 0.81%	2,742,944 $102 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $33.4 Million - $36.9 Million	817,822 Added 42.98%	2,720,800 $121 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $31.1 Million - $36.7 Million	817,400 Added 75.3%	1,902,978 $80.8 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $44.8 Million - $49.8 Million	1,085,578 New	1,085,578 $47.1 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $3.35 Million - $3.77 Million	-95,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $1.56 Million - $1.98 Million	47,140 Added 98.5%	95,000 $3.42 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $1.65 Million - $2.02 Million	47,860 New	47,860 $1.83 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $16.4 Million - $29.1 Million	-636,554 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $24.1 Million - $28.9 Million	636,554 New	636,554 $28.8 Million
Q3 2019 Nov 15, 2019	SELL	$40.31 - $43.45 $1.97 Million - $2.12 Million	-48,807 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $1.33 Million - $1.64 Million	38,135 Added 357.34%	48,807 $2.1 Million
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $4.51 Million - $5.58 Million	-137,040 Reduced 92.78%	10,672 $410,000
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $92.4 Million - $114 Million	-2,912,215 Reduced 95.17%	147,712 $5.22 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $52.2 Million - $61.4 Million	1,590,627 Added 108.26%	3,059,927 $118 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $9.95 Million - $12.7 Million	370,800 Added 33.76%	1,469,300 $48 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $27.7 Million - $31.4 Million	1,098,500 New	1,098,500 $30 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $3.11 Million - $3.74 Million	-125,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $3.3 Million - $3.66 Million	125,500	125,500 $3.66 Million

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account